For instance, monoclonal antibodies like tocilizumab (anti-IL-6) have been effective in dampening the cytokine storm in sepsis and are being explored in cancer, while TNF-α inhibitors like infliximab are used in autoimmune diseases and are being investigated for their ability to reduce inflammation-driven tumor progression. This evidence concerns the gene TNF and autoimmune disease.